Superior vena cava syndrome epidemiology and demographics

Jump to navigation Jump to search

Superior Vena Cava Syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Superior Vena Cava Syndrome from Other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Radiation Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Superior vena cava syndrome epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Superior vena cava syndrome epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Superior vena cava syndrome epidemiology and demographics

CDC on Superior vena cava syndrome epidemiology and demographics

Superior vena cava syndrome epidemiology and demographics in the news

Blogs on Superior vena cava syndrome epidemiology and demographics

Directions to Hospitals Treating Superior vena cava syndrome

Risk calculators and risk factors for Superior vena cava syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]

Overview

Superior vena cava syndrome is a common oncologic emergency. The incidence rate in the United States of SVCS is approximately 15,000 individuals each year. The incidence of superior vena cava syndrome increases with age; the median age of diagnosis is between 40-60 years. Males are more commonly affected with superior vena cava syndrome than females.[1]

Epidemiology and demographics

Prevalence

  • The prevalence of superior vena cava syndrome remains unknown.[1]

Incidence

  • In the United States, the incidence of superior vena cava syndrome is 15,000 individuals each year.[1]

Gender

  • Males are more commonly affected with superior vena cava syndrome than females due to the higher incidence of lung cancer among males.[2]

Race

  • The prevalence of SVCS does not vary by race. However, depending on the type of cancer a racial predilection may be possible.[1]

References

  1. 1.0 1.1 1.2 1.3 Higdon ML, Higdon JA (2006). "Treatment of oncologic emergencies". Am Fam Physician. 74 (11): 1873–80. PMID 17168344.
  2. Carter BW, Erasmus JJ (2015). "Acute Thoracic Findings in Oncologic Patients". J Thorac Imaging. 30 (4): 233–46. doi:10.1097/RTI.0000000000000148. PMID 25803363.

Template:WH Template:WS